Abstract
Backgroud
The recurrence rate of chronic rhinosinusitis with nasal polyps (CRSwNP) is positively correlated with eosinophil infiltration. Increased interleukin (IL)-19 and eosinophil chemokine RANTES levels have been reported in patients with CRSwNP. This study aimed to clarify the role of IL-19 in mediating RANTES expression and eosinophilic infiltration in eosinophilic CRSwNP (Eos CRSwNP).
Methods
Nasal tissue samples were obtained from patients with CRSwNP and controls. The expression of IL-19, its receptors, ECP, and RANTES in tissues was investigated. Primary human nasal epithelial cells (HNECs) and nasal polyp tissue blocks were cultured, then stimulated by IL-19; ERK phosphorylation, NF-κB pathway activation, RANTES level, eosinophils migration and infiltration were detected using RT-qPCR, ELISA, western blotting, HE, immunohistochemistry, immunofluorescence staining, confocal microscopy, and transwell migration assay.
Results
The expression of IL-19 and its receptors (IL-20R1/IL-20R2), eosinophil cationic protein, and RANTES in nasal tissues from patients with Eos CRSwNP was significantly increased compared to that in non-Eos CRSwNP and control subjects. IL-19 co-localized with RANTES in nasal tissues and significantly elevated RANTES expression in HNECs. IL-19-blocking antibody and siRNA knockdown of IL-20R1 ameliorated the effect of IL-19 on RANTES secretion in HNECs. Moreover, IL-19-induced RANTES upregulation was associated with the activation of the ERK and NF-κB pathways. NF-κB activation was mediated by the ERK pathway in IL-19-treated HNECs, and IL-19 enhanced eosinophil infiltration in nasal polyp tissue blocks.
Conclusions
Our findings indicate that IL-19 promotes RANTES expression via the ERK/NF-κB pathway in HNECs and is implicated in eosinophil infiltration in patients with Eos CRSwNP.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities. Allergy. 2015;70(5):533–9. https://doi.org/10.1111/all.12577.
Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. https://doi.org/10.4193/Rhin20.600.
Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol. 2017;12:331–57. https://doi.org/10.1146/annurev-pathol-052016-100401.
Lou H, Meng Y, Piao Y, Zhang N, Bachert C, Wang C, Zhang L. Cellular phenotyping of chronic rhinosinusitis with nasal polyps. Rhinology. 2016;54(2):150–9. https://doi.org/10.4193/Rhino15.271.
Lou H, Meng Y, Piao Y, Wang C, Zhang L, Bachert C. Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population. Am J Rhinol Allergy. 2015;29(5):350–6. https://doi.org/10.2500/ajra.2015.29.4231.
Ikeda K, Shiozawa A, Ono N, Kusunoki T, Hirotsu M, Homma H, Saitoh T, Murata J. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope. 2013;123(11):E1-9. https://doi.org/10.1002/lary.24154.
Lampinen M, Carlson M, Håkansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy. 2004;59(8):793–805. https://doi.org/10.1111/j.1398-9995.2004.00469.x.
Kapp A, Zeck-Kapp G, Czech W, Schöpf E. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J Invest Dermatol. 1994;102(6):906–14. https://doi.org/10.1111/1523-1747.ep12383399.
Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol. 1994;153(5):2153–60.
Bystrom J, Amin K, Bishop-Bailey D. Analysing the eosinophil cationic protein–a clue to the function of the eosinophil granulocyte. Respir Res. 2011;12:10. https://doi.org/10.1186/1465-9921-12-10.
Terada N, Maesako K, Hamano N, Ikeda T, Sai M, Yamashita T, Fukuda S, Konno A. RANTES production in nasal epithelial cells and endothelial cells. J Allergy Clin Immunol. 1996;98(6 Pt 2):S230–7. https://doi.org/10.1016/s0091-6749(96)70071-4.
Kuna P, Alam R, Ruta U, Gorski P. RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo. Am J Respir Crit Care Med. 1998;157(3 Pt 1):873–9. https://doi.org/10.1164/ajrccm.157.3.9610052.
Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines–from host defence to tissue homeostasis. Nat Rev Immunol. 2014;14(12):783–95. https://doi.org/10.1038/nri3766.
Autieri MV. IL-19 and other IL-20 family member cytokines in vascular inflammatory diseases. Front Immunol. 2018;9:700. https://doi.org/10.3389/fimmu.2018.00700.
Datta Mitra A, Raychaudhuri SP, Abria CJ, Mitra A, Wright R, Ray R, Kundu-Raychaudhuri S. 1α,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis. J Invest Dermatol. 2013;133(6):1556–64. https://doi.org/10.1038/jid.2013.3.
Li HH, Cheng HH, Sun KH, Wei CC, Li CF, Chen WC, Wu WM, Chang MS. Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis. Clin Immunol. 2008;129(2):277–85. https://doi.org/10.1016/j.clim.2008.07.006.
Weng YH, Chen WY, Lin YL, Wang JY, Chang MS. Blocking IL-19 signaling ameliorates allergen-induced airway inflammation. Front Immunol. 2019;10:968. https://doi.org/10.3389/fimmu.2019.00968.
Li X, Huang J, Chen X, Lai X, Huang Z, Li Y, Li S, Chang L, Zhang G. IL-19 induced by IL-13/IL-17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP-9 expression via ERK/NF-κB signaling pathway. Clin Transl Allergy. 2021;11(1): e12003. https://doi.org/10.1002/clt2.12003.
Lai X, Li X, Chang L, et al. IL-19 Up-regulates mucin 5AC production in patients with chronic rhinosinusitis via STAT3 pathway. Front Immunol. 2019;10:1682. https://doi.org/10.3389/fimmu.2019.01682.
Cao PP, Li HB, Wang BF, Wang SB, You XJ, Cui YH, Wang DY, Desrosiers M, Liu Z. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009;124(3):478–84, 484.e12. https://doi.org/10.1016/j.jaci.2009.05.017.
Chen X, Chang L, Li X, et al. Tc17/IL-17A up-regulated the expression of MMP-9 via NF-κB pathway in nasal epithelial cells of patients with chronic rhinosinusitis. Front Immunol. 2018;9:2121. https://doi.org/10.3389/fimmu.2018.02121.
Yang LY, Li X, Li WT, Huang JC, Wang ZY, Huang ZZ, Chang LH, Zhang GH. Vγ1+ γδT cells are correlated with increasing expression of eosinophil cationic protein and metalloproteinase-7 in chronic rhinosinusitis with nasal polyps inducing the formation of edema. Allergy Asthma Immunol Res. 2017;9(2):142–51. https://doi.org/10.4168/aair.2017.9.2.142.
Yeh DY, Wu CC, Chin YP, Lu CJ, Wang YH, Chen MC. Mechanisms of human lymphotoxin beta receptor activation on upregulation of CCL5/RANTES production. Int Immunopharmacol. 2015;28(1):220–9. https://doi.org/10.1016/j.intimp.2015.06.010.
Khunchai S, Junking M, Suttitheptumrong A, Kooptiwut S, Haegeman G, Limjindaporn T, Yenchitsomanus PT. NF-κB is required for dengue virus NS5-induced RANTES expression. Virus Res. 2015;197:92–100. https://doi.org/10.1016/j.virusres.2014.12.007.
Wang QJ, Zhang AL, Kang ZQ, Zhang ZT, Wang YS. Exogenous IL-19 mediates downregulation of TGF-β through Erk and p38 pathway to inhibit epidural fibrosis. Eur Rev Med Pharmacol Sci. 2019;23(17):7184–90. https://doi.org/10.26355/eurrev_201909_18819.
Liao B, Liu JX, Li ZY, et al. Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes. Allergy. 2018;73(7):1459–69. https://doi.org/10.1111/all.13411.
Luo X, Xu Z, Zuo K, Deng J, Gao W, Jiang L, Xu L, Huang Z, Shi J, Lai Y. The changes of clinical and histological characteristics of chronic rhinosinusitis in 18 years: was there an inflammatory pattern shift in southern China. World Allergy Organ J. 2021;14(4): 100531. https://doi.org/10.1016/j.waojou.2021.100531.
Suzukawa M, Ohta K, Fukutomi Y, et al. Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: a Nationwide Cohort Study in Japan (NHOM Asthma Study). Allergol Int. 2022. https://doi.org/10.1016/j.alit.2022.06.002.
Fahey LM, Guzek R, Ruffner MA, Sullivan KE, Spergel J, Cianferoni A. EMSY is increased and activates TSLP & CCL5 expression in eosinophilic esophagitis. Pediatr Allergy Immunol. 2018;29(5):565–8. https://doi.org/10.1111/pai.12907.
Longino ES, Labby AB, Wu J, Chapurin N, Li P, Chandra RK, Turner JH, Chowdhury NI. Association of cytokine profile with prior treatment failure and revision surgery in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2022. https://doi.org/10.1002/alr.23035.
Chao PZ, Chou CM, Chen CH. Plasma RANTES and eotaxin levels are correlated with the severity of chronic rhinosinusitis. Eur Arch Otorhinolaryngol. 2012;269(11):2343–8. https://doi.org/10.1007/s00405-012-1927-5.
Liao SC, Cheng YC, Wang YC, et al. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol. 2004;173(11):6712–8. https://doi.org/10.4049/jimmunol.173.11.6712.
Kaymak T, Kaya B, Wuggenig P, et al. IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis. Gut. 2023;72(5):821–33. https://doi.org/10.1136/gutjnl-2022-327166.
Xiao M, Zhang W, Liu W, et al. Osteocytes regulate neutrophil development through IL-19: a potent cytokine for neutropenia treatment. Blood. 2021;137(25):3533–47. https://doi.org/10.1182/blood.2020007731.
Azuma YT, Fujita T, Izawa T, et al. IL-19 contributes to the development of nonalcoholic steatohepatitis by altering lipid metabolism. Cells. 2021. https://doi.org/10.3390/cells10123513.
An W, Yu Y, Zhang Y, Zhang Z, Yu Y, Zhao X. Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction. Br J Pharmacol. 2019;176(5):699–710. https://doi.org/10.1111/bph.14549.
Valent P, Degenfeld-Schonburg L, Sadovnik I, Horny HP, Arock M, Simon HU, Reiter A, Bochner BS. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity. Semin Immunopathol. 2021;43(3):423–38. https://doi.org/10.1007/s00281-021-00863-y.
Yun YH, Kim HY, Do BS, Kim HS. Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res. 2011;34(12):1313–20. https://doi.org/10.1038/hr.2011.132.
Casola A, Henderson A, Liu T, Garofalo RP, Brasier AR. Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation. Am J Physiol Lung Cell Mol Physiol. 2002;283(6):L1280–90. https://doi.org/10.1152/ajplung.00162.2002.
Kudo T, Lu H, Wu JY, Graham DY, Casola A, Yamaoka Y. Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun. 2005;73(11):7602–12. https://doi.org/10.1128/IAI.73.11.7602-7612.2005.
Fessele S, Boehlk S, Mojaat A, Miyamoto NG, Werner T, Nelson EL, Schlondorff D, Nelson PJ. Molecular and in silico characterization of a promoter module and C/EBP element that mediate LPS-induced RANTES/CCL5 expression in monocytic cells. FASEB J. 2001;15(3):577–9. https://doi.org/10.1096/fj.00-0459fje.
Liu S, Flores JJ, Li B, Deng S, Zuo G, Peng J, Tang J, Zhang JH. IL-20R activation via rIL-19 enhances hematoma resolution through the IL-20R1/ERK/Nrf2 pathway in an experimental GMH rat pup model. Oxid Med Cell Longev. 2021;2021:5913424. https://doi.org/10.1155/2021/5913424.
Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607–32. https://doi.org/10.1038/s41580-020-0255-7.
Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G. NF-κB: blending metabolism, immunity, and inflammation. Trends Immunol. 2022;43(9):757–75. https://doi.org/10.1016/j.it.2022.07.004.
Acknowledgements
We sincerely thank Hongwei Bao and Zhouzhou Yao for the human sample collection. We also would like to thank the biobank of clinical resources of the third affiliated hospital of Sun Yat-sen University for human samples conservation. We would like to thank Editage for English language editing.
Funding
This study was supported by the National Natural Science Foundation of China (82101194, 81970859, 82101196, and 82071020), and the Medical Science and Technology Research Foundation of Guangdong Province (A2021024).
Author information
Authors and Affiliations
Contributions
ZH, XL, and YL performed RT-qPCR, western blotting, and confocal microscopy, and prepared the manuscript; WH and XL performed IHC; HW and XC participated in sample collection; YZ instructed data analysis; GZ and LC designed the study and revised the manuscript. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethics approval
This study was approved by the Ethical Committee of the Third Affiliated Hospital of Sun Yat-sen University (File No. [2022] 02-267-01). All patients were enrolled in the study only after informed consent were obtained.
Additional information
Responsible Editor: L Li.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, Z., Li, X., Li, Y. et al. Interleukin-19 enhances eosinophil infiltration through upregulation of epithelium-derived RANTES expression via the ERK/NF-κB signalling pathway in patients with eosinophilic CRSwNP. Inflamm. Res. 73, 499–513 (2024). https://doi.org/10.1007/s00011-024-01851-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-024-01851-2